QUOTED. 4 March 2021. Meghan Scanlon.
Boston Scientific has agreed to pay $1.07bn to acquire Lumenis’ surgical laser business from Baring Private Equity Asia. See what Meghan Scanlon, president of Boston Scientific’s urology and pelvic health business, said about it here.
“The acquisition will expand our global footprint throughout Europe and Asia and accelerate the delivery of our robust stone-management offerings to more urologists.” – Meghan Scanlon, president, Boston Scientic’s urology and pelvic health business
Click here for a free trial of Medtech Insight